$8B Verdict In J&J Risperdal Case
Johnson and Johnson have lost another lawsuit. A Philadelphia jury has found that the company ignored the risks that their drug, Risperdal posed. Risperdal is a popular antipsychotic, manufactured by J&J. According to the suit, one of the side effects of the drug is that it would cause young boys to develop breasts. Knowing this, Johnson & Johnson still pushed this medication to be used for children.
At the time, 9-year-old Nicholas Murray was prescribed the drug to help control symptoms related to autism. Soon after, Mr. Murray developed a condition known as gynecomastia. A condition that causes boys to grow female breasts. A jury previously awarded Mr. Murary $1.75 million in compensatory damages after finding that the labels at the time he was given the drug did not adequately warn doctors about the risks of breast growth in adolescents. At the time, the jury was not allowed to consider punitive damages, due to a global order in a mass tort program established to coordinate over 7,000 different Risperdal cases pending in Philadelphia County.
Warning labels at the time said that less than 2.3% of patients developed gynecomastia. However, in court, it was shown that the real rate was closer to 12%. J&J “massaged” the data to mask the connection between their drug and its adverse effects.
Have You Been Harmed From a Defective or Dangerous Drug?
If you have been injured from a dangerous drug? If you have been injured due to a pharmaceutical or medical manufacturer’s negligence, you need an attorney to recover damages for the pain and suffering you have experienced. The Begum Law Group Injury Lawyers knows exactly how to fight these companies to get you the compensation you deserve. Call us today at our office or contact us online. We are available day and night to set up your free consultation.